WO2024112417A1 - Microplaques à structure de rétention et leur procédé d'utilisation - Google Patents
Microplaques à structure de rétention et leur procédé d'utilisation Download PDFInfo
- Publication number
- WO2024112417A1 WO2024112417A1 PCT/US2023/036772 US2023036772W WO2024112417A1 WO 2024112417 A1 WO2024112417 A1 WO 2024112417A1 US 2023036772 W US2023036772 W US 2023036772W WO 2024112417 A1 WO2024112417 A1 WO 2024112417A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- millimeters
- microplate
- retention
- wells
- retention structure
- Prior art date
Links
- 230000014759 maintenance of location Effects 0.000 title claims abstract description 170
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000011159 matrix material Substances 0.000 claims abstract description 64
- 238000003556 assay Methods 0.000 claims abstract description 38
- 210000002220 organoid Anatomy 0.000 claims description 43
- 238000004891 communication Methods 0.000 claims description 7
- 238000004049 embossing Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 238000003491 array Methods 0.000 claims description 6
- 238000001746 injection moulding Methods 0.000 claims description 5
- 238000003384 imaging method Methods 0.000 claims description 4
- 230000000717 retained effect Effects 0.000 claims description 4
- 238000005266 casting Methods 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 30
- 239000000463 material Substances 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 239000012815 thermoplastic material Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 108010082117 matrigel Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003239 susceptibility assay Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
- B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/14—Scaffolds; Matrices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
- B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/22—Transparent or translucent parts
Definitions
- the present disclosure relates to microplates. More specifically, the present disclosure relates to microplates having at least one retention structure within a well for providing mechanical retention of a dome of a supporting matrix having suspended cells.
- two-dimensional cell cultures which provide a flat monolayer of cells, have helped researchers gain substantial knowledge and understanding of cell behavior, cell function and cell differentiation, researchers have observed that two-dimensional cell cultures provide markedly different behavior in cell polarity, stem cell differentiation, migration, gene expression, and tissue organization.
- a supporting matrix for example, a hydrogel, is used as the three-dimensional scaffold in the organoid culture dome method.
- the present disclosure relates to technology for three-dimensional organoid culture dome method.
- the organoid culture dome method is an established procedure for forming dome structures in wells of microplates using a supporting matrix. While three-dimensional dome structures are commonly used in organoid models, there are several drawbacks to the organoid culture dome method.
- forming three-dimensional dome structures within a well of a microplate requires extensive training and practice by an individual, and even still, results can be variable depending on the skill level of the individual. For example, the sizes of the dome structures can vary significantly since the individual is required to quickly disperse droplets into the wells to avoid gelation of the supporting matrix during the process. Having size variations of domes is not optimal for organoid culture consistency.
- the domes are typically randomly placed when positioning multiple domes within a well. If the domes are placed too closely to each other, then dome fusion can occur due to the proximity of the neighboring domes. Moreover, a dome can collapse if an individual places the dome too close to the sidewall of a microplate well. Yet another common problem with the formation of dome structures is the loss of domes during the medium exchange process as a result of medium seeping between the domes and the surface of the microplate well.
- the aforementioned challenges may be at least partially addressed by providing at least one retention structure within a well of a microplate for providing mechanical retention of a dome of a supporting matrix.
- An exemplary embodiment of the present disclosure provides a microplate comprising a a plurality of wells for receiving a dome of a supporting matrix, each well of the plurality of wells comprising a bottom surface comprising at least one retention structure to provide mechanical retention of one of the assay samples, wherein the at least one retention structure may comprise a diameter ranging between about 0.5 millimeters and about 5 millimeters and a height, and wherein a ratio of the height to the diameter may range from about 10% to about 30%.
- each well of the plurality of wells may comprise a plurality of retention structures configured to receive one of the assay samples.
- the at least one retention structure may comprise a continuous wall, and the height of the at least one retention structure may range between about 1 millimeter and about 3 millimeters. Further, in some embodiments, the continuous wall may be configured to retain a volume of one of the assay samples deposited within the continuous wall ranging between about 5 microliters and about 50 microliters.
- the at least one retention structure may comprise a plurality of discontinuous walls, and the height of the at least one retention structure may range between about 1 millimeter and about 3 millimeters.
- the discontinuous walls may be configured to retain a volume of one of the assay samples deposited within the discontinuous walls ranging between about 5 microliters and about 50 microliters.
- the at least one retention structure may comprise a plurality of radially spaced apart posts.
- Each post may comprise a height ranging between about 1 millimeter and about 3 millimeters.
- the plurality of radially spaced apart posts in some embodiments, may be configured to retain a volume of one of the assay samples deposited within the radially spaced apart posts ranging between about 5 microliters and about 50 microliters.
- each well of the plurality of wells may include a first retention structure centrally positioned on the bottom surface and in fluid communication with a set of second retention structures positioned on the bottom surface and spaced from the first retention structure.
- Each well may include a plurality of fluidic channels extending between the first retention structure and the set of second retention structures to provide fluid communication therebetween, each of the fluidic channels comprising an inlet for receiving cells suspended in the supporting matrix from the first retention structure and an outlet for delivering cells suspended in the supporting matrix to one of the second retention structures in the set of second retention structures.
- the plurality of wells may be arranged in rectilinear arrays of rows and columns to form a matrix, and each well of the plurality of wells may be a flat bottom well.
- the matrix may comprise, for example, a total of 6 wells, 12 wells, 24 wells, or 48 wells.
- the thickness of the bottom wall of the microplate may range between about 0.05 millimeters and about 1 millimeters
- the at least one retention structure may be formed by injection molding, hot pin embossing, or casting.
- the at least one retention structure in some embodiments, may include a top edge formed with one of a beveled edge, a rounded edge, or a chamfered edge.
- the at least one retention structure in some embodiments may be optically transmissive.
- Another exemplary embodiment of the present disclosure provides a method of using a microplate comprising providing a microplate comprising a plurality of wells arranged in rectilinear arrays of rows and columns for receiving assay samples of suspended cells in a supporting matrix, each well of the plurality of wells comprising a bottom surface comprising a plurality of retention structures to provide mechanical retention of one of the assay samples within each retention structure, wherein each retention structure may comprise a diameter ranging between about 0.5 millimeters and about 5 millimeters and a height, and wherein a ratio of the height to the diameter may range from about 10% to about 30%; and depositing an assay sample within each of the retention structures.
- the method may comprise incubating the supporting matrix within each of the retention structures to polymerize the supporting matrix, and overlaying the supporting matrix with media containing niche factors to form organoids in the supporting matrix retained within each of the retention structures.
- the method may further comprise imaging the organoids.
- the method may include performing an experiment using the organoids in the supporting matrix retained within each of the retention structures. Further, in some embodiments, the method may comprise a step of warming the microplate before the assay sample is deposited within each of the retention structures.
- the plurality of optically transmissive retention structures was formed by molding recesses in the bottom of each of the plurality of wells. In another embodiment, the plurality of optically transmissive retention structures was formed by hot pin embossing recesses into the bottom of each well of the plurality of wells.
- FIG. 1 is a top plan view of an exemplary microplate having retention structures within a plurality of wells
- FIG. 2 is a partial top plan view of the exemplary microplate shown in FIG. 1;
- FIG. 3 is a cross-sectional view of a plurality of wells of the exemplary microplate taken from lines 3-3 of FIG. 3;
- FIG. 4 is a cross-sectional view of a plurality of wells of the exemplary microplate taken from lines 4-4 of FIG. 3 ;
- FIG. 5 is a cross-sectional view of one of the retention structures shown in FIGS. 3 and 4 including a partial view of a continuous wall and having a dome of supporting matrix;
- FIG. 6 is a cross-sectional view of one of the retention structures shown in FIGS. 3 and 4, except showing discontinuous walls;
- FIG. 7 is a cross-sectional view of one of the retention structures shown in FIGS. 3 and 4, except showing a cavity without a wall protruding from the bottom surface of the well and having a dome of supporting matrix;
- FIG. 8 is a perspective view of a well of an exemplary microplate having sets of posts forming each of the retention structures;
- FIG. 9 is a cross-sectional view of the retention structure shown in FIGS. 3 and 4, except without a cavity and with the retention structure having a beveled edge;
- FIG. 10 is a top plan view of an exemplary microplate having retention structures and showing channels fluidly connecting the retention structures;
- FIG. 11 A is a cross-sectional view of one of the retention structures within one of the wells of the exemplary microplate taken from lines 11-11 of FIG. 10, showing hot pin embossing forming a cavity;
- FIG. 1 IB is a cross-sectional view of the retention structure shown in FIG. 11A after the hot pin embossing.
- FIG. 12 is a flow chart of a method of using the microplate in accordance with an exemplary embodiment of the present disclosure.
- the term “substantially” is synonymous with terms such as “nearly,” “very nearly,” “about,” “approximately,” “around,” “bordering on,” “close to,” “essentially,” “in the neighborhood of,” “in the vicinity of,” etc., and such terms may be used interchangeably as appearing in the specification and claims.
- proximate is synonymous with terms such as “nearby,” “close,” “adjacent,” “neighboring,” “immediate,” “adjoining,” etc., and such terms may be used interchangeably as appearing in the specification and claims.
- the term “approximately” is intended to mean values within ten percent of the specified value.
- a device comprising a first element, a second element and/or a third element is intended to be construed as any one of the following structural arrangements: a device comprising a first element; a device comprising a second element; a device comprising a third element; a device comprising a first element and a second element; a device comprising a first element and a third element; a device comprising a first element, a second element and a third element; or, a device comprising a second element and a third element.
- a device comprising at least one of: a first element; a second element; and, a third element, is intended to be construed as any one of the following structural arrangements: a device comprising a first element; a device comprising a second element; a device comprising a third element; a device comprising a first element and a second element; a device comprising a first element and a third element; a device comprising a first element, a second element and a third element; or, a device comprising a second element and a third element.
- a similar interpretation is intended when the phrase “used in at least one of” is used herein.
- references herein to the positions of elements are merely used to describe the orientation of various elements in the figures.
- the orientation of various elements may differ according to other exemplary embodiments, and such variations are intended to be encompassed by the present disclosure.
- compositions, articles, and methods of the disclosure can include any value, or any combination of the values, specific values, more specific values, and preferred values described herein, including explicit or implicit intermediate values and ranges.
- a microplate having retention structures and methods of using the same are described.
- the retention structures can provide control for positioning organoid domes within wells of a microplate. Having at least one retention structure within a well of a microplate may allow more even distribution of organoid domes within a well and, thus, may allow nutrients from the media to be used more evenly among the domes during the culture. It can also help standardize and improve the quality of the organoid culture.
- the microplate having retention structures can provide better control for the organoid dome sizes, especially with manual operation by an individual. Further, the retention structures can provide physical support and protection to the organoid domes and reduce the loss of organoid domes during operational procedures such as medium exchange or drug treatment.
- the deck 104 may support rectilinear arrays of rows and columns to form a matrix, although in further embodiments, other array configurations may be adopted. For example, as shown in FIG. 1, the deck 104 may support 24 wells. However, the deck 104 may support fewer or additional wells.
- the microplate 100 may include a matrix comprising a total of 6 wells, 12 wells, 48 wells, or more.
- the deck 104 can be formed in other geometrical shapes depending on the desired number of wells and/or the desired use of the microplate 100.
- the microplate 100 may optionally include a microplate cover (not shown) and a microplate base (not shown).
- the microplate 100 may be made of polymeric material.
- the microplate 100 may comprise polystyrene.
- the microplate 100 can be made of clear polystyrene, solid black polystyrene, or white polystyrene.
- the microplate 100 may comprise an optically clear bottom with either a black opaque polystyrene microplate body or a white opaque polystyrene microplate body.
- the microplate 100 may alternatively be made of polycarbonate, polypropylene, poly vinyl chloride (PVC), polyethylene terephthalate, UV transparent material, glass material, cyclic olefin copolymer (COC), or a combination thereof.
- the microplate 100 may be made of other materials.
- the bottom 116 of each well 102 comprises a bottom surface 118 that can be treated or not treated.
- the bottom surface 118 may be tissue culture treated or coated with poly-D-lysine (PDL), collagen, fibronectin, Corning® BioCoatTM surfaces, or Coming® PureCoatTM surfaces.
- the bottom surface 118 is a Corning® CellBIND® Surface.
- Each well 102 may comprise at least one retention structure 130 for mechanically retaining a supporting matrix as described below.
- organoid cells may be mixed with a supporting matrix that provides a three-dimensional scaffold.
- the organoid cells are mixed with a supporting matrix using the organoid culture dome method.
- the supporting matrix resembles an extracellular matrix, for example, a hydrogel that supports organoid growth and differentiation.
- An example supporting matrix that can be used is the Corning® Matrigel® matrix.
- the supporting matrix may be placed on ice to maintain the supporting matrix at a low temperature of approximately 0°C and then a droplet having suspended cells ranging from about 5 microliters to about 50 microliters is dispersed within the boundary of a retention structure 130.
- the size of the retention structure 130 can be selected based on the desired size of the organoid domes as discussed in more detail below. Further, other supporting matrix materials can be used. Similarly sized droplets are disposed in neighboring retention structures 130 within a well 102 and within other wells 102.
- the microplate 100 may be pre- warmed in an incubator at about 36°C to about 40°C. In one embodiment, the incubator may be warmed to approximately 37°C before the droplets are dispersed on the microplate 100.
- the microplate 100 may be pre- warmed overnight.
- the size of the droplets may be determined at least in part by the number of wells as well as the height and diameter of the retention structure 130 within each well as discussed in more detail farther below.
- the supporting matrix may be incubated at 37° C to polymerize the gel and form a dome structure.
- the supporting matrix may be gellified in about 5 to about 10 minutes, whereupon gellified material becomes a semisolid dome structure with organoid cells embedded in the structure. Media containing niche factors can be applied to the polymerized dome such that organoids form and enlarge.
- the term “assay sample” refers to a droplet of cells in a supporting matrix that forms an organoid dome structure.
- each well 102 may include a single retention structure 130.
- each well may contain a plurality of retention structures 130.
- each well 102 may include between approximately 1 to 50 retention structures.
- a well of a 24- well plate may comprise 5 to 7 retention structures 130 at the bottom 116 of each well, while a 6- well plate may comprise 20 to 30 retention structures 130 at the bottom 116 of each well.
- the retention structure 130 mechanically retains a droplet of cells suspended in a scaffolding material that resembles an extracellular matrix, also referred to as a supporting matrix, placed within a boundary defined by the retention structure 130, as described in more detail below.
- each retention structure 130 can include a cavity 132 defined by walls 134 and a cavity bottom surface 128 and provides a three-dimensional region to retain a droplet of supporting matrix having suspended cells 180 that forms a dome structure.
- the size of the retention structure 130 and number of wells 102 of a microplate 100 can be selected based on the desired size of the organoid domes.
- the retention structure 130 may comprise a raised wall 136 protruding from the bottom surface 118 of the well 102 and a cavity 132.
- the raised wall 136 and the bottom surface 118 of the well 102 may be integrally formed.
- the raised wall 136 may be a continuous wall 138 having a closed perimeter or circumference.
- the retention structure 130 may be a closed circle, ellipse, polygon, or other shape.
- Each retention structure 130 includes a diameter (Di), and a height (Hi).
- the diameter (Di) is an inner diameter measured from the inner walls of the retention structures 130.
- the height (Hi) is measured from the cavity bottom surface 128 to a top surface 140 of the continuous wall 138.
- the diameter (Di) may range between about 0.5 millimeters and about 5 millimeters.
- the diameter (Di) may range between about 0.5 millimeters and 2.5 millimeters, between about 2.5 millimeters and 5.0 millimeters, between about 0.5 millimeters and 1.0 millimeters, between about 1.0 millimeter and about 1.5 millimeter, between about 1.5 millimeters and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between about 3.0 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4.0 millimeters, between about 4.0 millimeters and about 4.5 millimeters, or between about 4.5 millimeters and about 5.0 millimeters, including all ranges and subranges therebetween.
- the height (Hi) of the continuous wall 138 of the retention structures 130 may range between about 1 millimeter and about 3 millimeters.
- the height (Hi) may range between about 1 millimeter and about 1.5 millimeters, between about 1.5 millimeter and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, or between about 2.5 millimeters and about 3 millimeters, including all ranges and subranges therebetween.
- the height (Hi) and diameter (Di) can be selected based on the desired dome size to be formed from the dispensed droplet of cells suspended in the supporting matrix 180. That is, the retention structure 130 can be configured to hold a particular droplet size in a range of about 5 microliters to about 50 microliters.
- each retention structure 130 can hold a droplet size of about 5 microliters. In other embodiments, each retention structure 130 can hold a droplet size of about 10 microliters. In yet other embodiments, each retention structure can hold a droplet size of about 50 microliters.
- the droplet size may range between about 5 microliters and about 10 microliters, between about 10 microliters and about 15 microliters, between about 15 microliters and about 20 microliters, between about 5 microliters and about 25 microliters, between about 20 microliters and about 25 microliters, between about 25 microliters and about 30 microliters, between about 30 microliters and about 35 microliters, between about 25 microliters and about 50 microliters, between about 35 microliters and about 40 microliters, between about 40 microliters and about 45 microliters, or between about 45 microliters and about 50 microliters, including all ranges and subranges therebetween.
- Retention structure size can correspond to the number of wells 102 in each microplate 100 as described above. For example, 5 to 7 domes are usually generated with an average volume of about 5 to about 10 microliters and deposited on a 24-well plate. In some embodiments, a ratio of the height (H) to the diameter (D) may range from about 10% to about 30%.
- the height (Hi) to diameter (Di) ratio may be about 10% to 12%, 10% to 14%, 10% to 16%, or 10% to 18%, from about 10% to about 20%, from about 12% to about 20%, from about 14% to about 20%, from about 16% to about 20%, from about 18% to about 20%, from about 20% to about 30%, from about 22% to about 30%, from about 24% to about 30%, from about 26% to about 30%, from about 28% to about 30%, including all ranges and subranges therebetween.
- the height (Hi) to diameter (Di) ratio may be about 30%.
- the continuous wall 138 of a retention structure 130 may be configured to retain a volume of one of the assay samples deposited within the continuous wall 138 ranging between about 5 microliters and about 50 microliters.
- the supporting matrix may expand in volume due to the absorption of culture media when the culture media is added to the dome culture.
- the volume of the organoid dome may increase to an expanded volume of 100 microliters.
- the diameter of the organoid dome may be about 2 millimeters to about 4 millimeters.
- the diameter of the organoid dome may be between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between about 3.0 millimeters and about 3.5 millimeters, or between about 3.5 millimeters and about 4.0 millimeters, including all ranges and subranges therebetween.
- the retention structure 130 may include a raised wall 136, wherein the raised wall 136 is a discontinuous wall or set of discontinuous walls 142.
- FIG. 6 illustrates a three-dimensional region to retain the droplet of supporting matrix having suspended cells 180 that forms a dome structure, but with the droplet 180 removed to show the discontinuous walls 142.
- the discontinuous walls 142 comprise an opening within the perimeter or circumference of the discontinuous walls.
- the retention structure 130 can include a set of partial walls in the shape of a circle.
- the retention structure 130 can include a set of partial walls in the shape of an oval, polygon, or other shape.
- Each retention structure 130 includes a diameter (D2), and a height (H2).
- the diameter (D2) is an inner diameter measured from the inner walls of the retention structures 130.
- the height (H2) is measured from the cavity bottom surface 128 to a top surface 140 of the discontinuous walls 142.
- the diameter (D2) may range between about 0.5 millimeters and about 5 millimeters.
- the diameter (D2) may range between about 0.5 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 5.0 millimeters, between about 0.5 millimeters and about 1.0 millimeters, between about 1.0 millimeter and about 1.5 millimeter, between about 1.5 millimeters and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between about 3.0 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4.0 millimeters, between about 4.0 millimeters and about 4.5 millimeters, or between about 4.5 millimeters and about 5.0 millimeters, including all ranges and subranges therebetween.
- the height of the discontinuous walls 142 of the retention structures 130 ranges may be between about 1 millimeter and about 3 millimeters.
- the height (H2) may range between about 1 millimeter and about 1.5 millimeters, between about 1.5 millimeter and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, or between about 2.5 millimeters and about 3 millimeters, including all ranges and subranges therebetween.
- the height (H2) and diameter (D2) can be selected based on the desired dome size formed from the dispensed droplet of cells suspended in the supporting matrix.
- a ratio of the height (H2) to the diameter (D2) may range from about 10% to about 30%, for example in a range from about 10% to about 12%, from about 10% to about 14%, from about 10% to about
- the discontinuous walls 142 of a retention structure 130 may be configured to retain a volume of one of the assay samples deposited within the discontinuous walls 142 ranging between about 5 microliters and about 50 microliters.
- the supporting matrix may expand in volume due to the absorption of culture media when the culture media is added to the dome culture.
- the volume of the organoid dome may increase to an expanded volume of 100 microliters or more.
- the retention structure 130 may include the cavity 132 without a raised wall.
- the cavity 132 defined by cavity walls 134 and a cavity bottom surface 128, provides a three-dimensional region to retain the droplet of supporting matrix having suspended cells 180 that forms a dome structure.
- the retention structure 130 includes a diameter (D3), and a height (H3).
- the diameter (D3) is an inner diameter measured from the inner walls of the cavity 132.
- the height (H3) is measured from the cavity bottom surface 128 to the top of the cavity 132, which is the bottom surface 118 of the well 102.
- the diameter (D3) may range between about 0.5 millimeters and about 5 millimeters.
- the diameter (D3) may range between about 0.5 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 5.0 millimeters, between about 0.5 millimeters and about 1.0 millimeters, between about 1.0 millimeter and about 1.5 millimeter, between about 1.5 millimeters and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between about 3.0 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4.0 millimeters, between about 4.0 millimeters and about 4.5 millimeters, or between about 4.5 millimeters and about 5.0 millimeters, including all ranges and subranges therebetween.
- the height of the cavity walls 134 of the retention structures 130 may range between about 0.5 millimeter and about 3 millimeters.
- the height (H3) may range between about 1 millimeter and about 1.5 millimeters, between about 1.5 millimeter and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3 millimeters, including all ranges and subranges therebetween.
- the height (H3) and diameter (D3) can be selected based on the desired dome size formed from the dispensed droplet of cells suspended in the supporting matrix.
- a ratio of the height (H3) to the diameter (D3) may range from about 5% to about 30%.
- the cavity 132 of a retention structure 130 may be configured to retain a volume of one of the droplets of supporting matrix having suspended cells 180 which forms a dome structure deposited within the cavity 132, wherein the volume may range between about 5 microliters and about 50 microliters.
- the volume range may be between about 5 microliters and about 10 microliters, between about 10 microliters and about 15 microliters, between about 15 microliters and about 20 microliters, between about 5 microliters and about 25 microliters, between about 20 microliters and about 25 microliters, between about 25 microliters and about 30 microliters, between about 30 microliters and about 35 microliters, between about 25 microliters and about 50 microliters, between about 35 microliters and about 40 microliters, between about 40 microliters and about 45 microliters, or between about 45 microliters and about 50 microliters, including all ranges and subranges therebetween. It should be appreciated, however, that the supporting matrix may expand in volume due to the absorption of culture media.
- the volume of the organoid dome may increase to an expanded volume of 100 microliters or more.
- the organoid dome may increase to an expanded volume of between about 10 microliters to about 200 microliters, between about 10 microliters and about 50 microliters, between about 50 microliters and about 100 microliters, between about 100 microliters and about 150 microliters, or between about 150 microliters and about 200 microliters, including all ranges and subranges therebetween.
- the retention structure 130 may comprise a plurality of radially spaced apart posts 150, each plurality of radially spaced apart posts 150 forming a set.
- each well 102 may comprise a plurality of retention structures 130.
- FIG. 8 seven (7) retention structures 130, each retention structure comprising a plurality of radially spaced apart posts 150, are shown.
- Each set of posts 150 forming a retention structure 130 may alternatively form an ellipse, polygon, or other shape.
- the posts 150 may each be cylindrical. However, other shapes are possible, including elliptical or polygonal, or including, but not limited to, triangular, square, or rectangular.
- each retention structure 130 may surround a cavity, for example cavity 132, as shown in FIG. 7, within the bottom 116 of the well 102. In other embodiments, the posts 150 may be arranged on the bottom 116 of the well 102 without a cavity.
- the retention structure 130 of posts 150 may include 3 to 4 posts. However, additional posts 150 may be used to form a retention structure 130.
- Each retention structure 130 of posts 150 includes a diameter (D4).
- the diameter (D4) is an inner diameter measured from the inner walls 152 of the posts 150. In embodiments, the diameter (D4) may range between about 0.5 millimeters and about 5 millimeters.
- the diameter (D4) may range between about 0.5 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 5.0 millimeters, between about 0.5 millimeters and about 1.0 millimeters, between about 1.0 millimeter and about 1.5 millimeter, between about 1.5 millimeters and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between about 3.0 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4.0 millimeters, between about 4.0 millimeters and about 4.5 millimeters, or between about 4.5 millimeters and about 5.0 millimeters, including all ranges and subranges therebetween.
- Each post comprises a height (H4) that may range between about 1 millimeter and about 6 millimeters.
- the height (H4) may range between about 1 millimeter and about 1.5 millimeters, between about 1.5 millimeters and about 2 millimeters, or between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3 millimeters, between about 3 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4 millimeters, between about 4 millimeters and about 4.5 millimeters, between about 4.5 millimeters and about 5 millimeters, between about 5 millimeters and about 5.5 millimeters, or between about 5.5 millimeters and about 6 millimeters.
- the height (H4) is measured from the bottom 116 of the well 102.
- the height (H4) of the posts 150 may be shorter than if the bottom 116 of each well 102 does not include a cavity.
- the posts 150 may be arranged to retain a volume of one of the droplets of supporting matrix having suspended cells 180 within the radially spaced apart posts 150 ranging between about 5 microliters and about 50 microliters.
- a ratio of the height (H4) to the diameter (D4) may range from about 10% to about 30%, for example from about 10% to 12%, from about 10% to about 14%, from about 10% to about 16%, from about 10% to about 18%, from about 10% to about 20%, from about 12% to about 20%, from about 14% to about 20%, from about 16% to about 20%, from about 18% to 20%, from about 20% to about 30%, from about 22% to about 30%, from about 24% to about 30%, from about 26% to about 30%, or from about 28% to about 30%, including all ranges and subranges therebetween.
- the posts 150 of each retention structure 130 may be configured to retain a volume of one of the assay samples deposited within the retention structure 130 ranging between about 5 microliters and about 50 microliters. However, the supporting matrix may expand in volume due to the absorption of culture media when the culture media is added to the dome culture. Thus, the volume of the assay sample may increase to an expanded volume of 100 microliters or more.
- the raised wall 136 shown in FIGS. 5 and 6, the cavity wall 134 shown in FIG. 7, and the posts 150 shown in FIG. 8 have a relatively short height (H) compared to the diameter (D) of the retention structure 130 to avoid substantial interference with dome recovery, while still (i) providing a physical barrier that protects the organoid dome from being detached due to liquid movement during medium exchange or drug treatment; and (ii) helping to retain the shape and position of the individual organoid domes.
- the retention structures 130 may comprise an optically transparent material.
- the retention structures 130 may be optically translucent.
- the microplate may also be optically transparent or optically translucent.
- each retention structure 130 may include an inwardly beveled edge 160 along the top portion 140 of the raised wall 136.
- the beveled edge 160 may have an angle less than about 90 degrees, for example less than about 75 degrees, less than 65 degrees, less than 60 degrees, or less than 50 degrees.
- the retention structures 130 may include an inwardly chamfered edge along the top portion 140 having an angle less than about 90 degrees, for example less than about 75 degrees, less than 65 degrees, less than 60 degrees, or less than 50 degrees.
- the retention structures 130 may include a rounded edge. Fabricating the retention structures 130 with a beveled, chamfered, or rounded edge can reduce the sharpness of the edge of the top portion 140 and improve mechanical retention of the retention structures 130.
- the microplate 100 may include a plurality of wells 102 comprising a retention structure 130a positioned on the bottom surface 118 of the well 102 that is in fluid communication with a set of retention structures 130b positioned on the bottom surface 118 of the well 102.
- the retention structure 130a may be centrally positioned on the bottom surface 118 of the well 102 while the set of retention structures 130b are radially spaced from the retention structure 130a.
- the retention structure 130a may be in fluid communication with a set of second retention structures 130b through a set of fluidic channels 170 extending between the retention structure 130a and the retention structures 130b to provide fluid communication therebetween.
- Each fluidic channel 170 comprises an inlet 172 for receiving cells suspended in the supporting matrix from the retention structure 130a and an outlet 174 for delivering cells suspended in the supporting matrix to at least one of the retention structures 130b.
- the cavities 132 in the microplate 100 in embodiments may be formed by a hot emboss molding method.
- the microplate 100 is manufactured by first softening the microplate bottom wall 112 material and then pressing the material against a mold 190.
- the shape of the mold 190 may be pressed and formed into the microplate bottom wall 112.
- the mold 190 may be in the shape of a polygonal column configured to form a polygonal cavity in the bottom wall 112.
- the shape of the mold 190 may be a cylindrical or elliptic cylinder.
- the raised wall 136 may be formed from excess material pushed out of the cavity during the formation of the cavities 132.
- the raised wall 136 may be a continuous wall 138 (as shown in FIG. 5) and in other embodiments, the raised wall 136 may be a discontinuous wall 142 (as shown in FIG. 6). After hot embossing the cavities 132, the microplate 100 may be cooled.
- the bottom wall of the microplate 100 may have a thickness ranging between about 0.05 millimeters and about 1 millimeters between about 0.05 millimeters and about 0.5 millimeters, between about 0.5 millimeters and about 0.8 millimeters, or between about 0.8 millimeters and about 1.0 millimeters, including all ranges and subranges therebetween.
- the hot embossed cavities may have a bottom thickness between about 0.02 and about 0.80 millimeters, between about 0.02 millimeters and about 0.1 millimeters, between about 0.1 millimeters and about 0.2 millimeters, or between about 0.2 millimeters and about 0.8 millimeters, including all ranges and subranges therebetween.
- the microplate 100 having cavities 132 may be formed by injection molding.
- a microplate 100 thermoplastic material is liquefied and then injected into a mold cavity of an injection molding machine.
- the mold cavity comprises shapes forming the microplate 100 comprising a plurality of wells 102 having cavities 132 as shown in FIG. 7.
- the shape of the cavities 132 formed may be polygonal.
- the shape of the cavities 132 formed may be cylindrical or elliptical.
- the mold cavity may further comprise shapes forming a raised wall 136 encompassing each of the cavities 132 (as shown in FIG. 5 and FIG. 1 IB).
- the raised wall 136 may be a continuous wall 138 and in other embodiments, the raised wall 136 may be a discontinuous wall 142 (as shown in FIG. 6).
- the injection molding machine cools the thermoplastic materials to solidify the material and create the microplate 100. The microplate may then be removed.
- the bottom wall of the microplate 100 may have a thickness ranging between about 0.05 millimeters and about 1 millimeters, between about 0.05 millimeters and about 0.5 millimeters, between about 0.5 millimeters and about 0.8 millimeters, or between about 0.8 millimeters to about 1.0 millimeters, including all ranges and subranges therebetween.
- the cavities 132 may comprise a bottom wall thickness ranging between about 0.02 to about 0.80 millimeters, between about 0.02 millimeters and about 0.1 millimeters, between about 0.1 millimeters and about 0.2 millimeters, or between about 0.2 millimeters and about 0.8 millimeters, including all ranges and subranges therebetween.
- the microplate 100 having cavities 132 may be formed by casting. In this process, a microplate 100 thermoplastic material is liquified and then introduced into a mold cavity.
- the mold cavity comprises shapes forming the microplate 100 comprising a plurality of wells 102 having cavities 132 as shown in FIG. 7.
- the shape of the cavities 132 formed may be polygonal. In other embodiments, the shape of the cavities 132 formed may be cylindrical or elliptical.
- the mold cavity may further comprise shapes forming a raised wall 136 encompassing each of the cavities 132 (as shown in FIGS. 5 and 1 IB).
- the raised wall 136 may be a continuous wall 138 and in other embodiments, the raised wall 136 may be a discontinuous wall 142 (as shown in FIG. 6).
- the liquified thermoplastic material is allowed to solidify to create the microplate 100.
- the microplate is then removed.
- the bottom wall of the microplate 100 may have a thickness ranging between about 0.05 millimeters and about 1 millimeters, and the cavities 132 may comprise a bottom thickness ranging between about 0.02 to about 0.80 millimeters.
- the bottom wall of the microplate 100 may have a thickness ranging between about 0.05 millimeters and about 0.5 millimeters, between about 0.5 millimeters and about 0.8 millimeters, between about 0.8 millimeters and about 1.0 millimeters, between about 0.02 millimeters and about 0.1 millimeters, between about 0.1 millimeters and about 0.2 millimeters, or between about 0.2 millimeters and about 0.8 millimeters, including all ranges and subranges therebetween.
- FIG. 12 presents a summary of the above teachings for using the above-described microplate 100.
- the flow chart of FIG. 12 illustrates an operation of the method 200.
- a microplate 100 comprising a bottom wall 112 comprising a plurality of wells 102 arranged in rectilinear arrays of rows and columns is provided.
- Each well 102 comprises a bottom surface 118 for receiving assay samples 180 of suspended cells in a supporting matrix.
- the bottom surface 118 comprises a plurality of retention structures 130 to provide mechanical retention of one of the assay samples 180 within each retention structure 130, wherein each retention structure 130 comprises a diameter that may range between about 0.5 millimeters and about 5 millimeters and a height, and wherein a ratio of the height (Hi) to the diameter (Di) may range from about 10% to about 30%.
- the diameter may range between about 0.5 millimeters and about 5.0 millimeters, for example between about 0.5 millimeters and about 1.0 millimeters, between about. 1.0 millimeter and about 1.5 millimeter, between about 1.5 millimeters and about 2 millimeters, between about 2 millimeters and about 2.5 millimeters, between about 2.5 millimeters and about 3.0 millimeters, between 3.0 millimeters and about 3.5 millimeters, between about 3.5 millimeters and about 4.0 millimeters, between about 4.0 millimeters and about 4.5 millimeters, or between about 4.5 millimeters and about 5.0 millimeters, including all ranges and subranges therebetween.
- the height (Hi) to diameter (Di) ratio of the retention structure 130 may be about 10% to 12%, 10% to 14%, 10% to 16%, or 10% to 18%, 10% to 20%, 12% to 20%, 14% to 20%, 16% to 20%, 18% to 20%, 20% to 30%, 22% to 30%, 24% to 30%, 26% to 30%, or 28% to 30%, including all ranges and subranges therebetween.
- the microplate 100 may be warmed before the assay sample 180 is deposited within each of the retention structures 130.
- the microplate 100 may be warmed in an incubator at a temperature in a range from about 36°C to about 40°C.
- the microplate 100 may be warmed overnight in an incubator at a temperature of 37° C.
- An assay sample 180 may be deposited within each of the retention structures 130 according to step 206.
- the assay samples 180 may then be incubated within each of the retention structures 130 to polymerize the supporting matrix according to step 208.
- the assay samples may be overlaid with media containing niche factors to form organoids in the supporting matrix retained within each of the retention structures 130.
- the organoids can be imaged. Three-dimensional imaging or four-dimensional imaging can be used to study the cellular structure of the organoids. Alternatively or additionally, according to step 214, an experiment can be conducted on the organoids.
- organoid assays can be conducted on the organoids, including but not limited to drug sensitivity assays and growth and viability assays, and other in vivo assays such as RNA and DNA isolation, immunohistochemistry, and genetic manipulation.
- the organoids can be propagated and expanded by removing the supporting matrix and dissociating the cells enzymatically or mechanically. The organoids can then be returned to culture conditions.
- the present disclosure provides a microplate having retention structures, and a method of using the same.
- the present disclosure contemplates that many changes and modifications may be made. Therefore, while embodiments of the microplate form and methods of using the same have been shown and described, persons skilled in the art will readily appreciate that various additional changes and modifications may be made without departing from the scope of the disclosure.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Microplaque comprenant une pluralité de puits destinés à accueillir un dôme d'une matrice de support, chaque puits de la pluralité de puits comprenant une surface inférieure dotée d'au moins une structure de rétention pour assurer la rétention mécanique d'un des échantillons de dosage, l'au moins une structure de rétention comprenant un diamètre compris entre environ 0,5 millimètres et environ 5 millimètres et une hauteur, le rapport entre la hauteur et le diamètre étant compris entre environ 10 % et environ 30 %, ainsi qu'un procédé d'utilisation de cette microplaque.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263426845P | 2022-11-21 | 2022-11-21 | |
US63/426,845 | 2022-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024112417A1 true WO2024112417A1 (fr) | 2024-05-30 |
Family
ID=89168307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/036772 WO2024112417A1 (fr) | 2022-11-21 | 2023-11-03 | Microplaques à structure de rétention et leur procédé d'utilisation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024112417A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170342363A1 (en) * | 2014-10-29 | 2017-11-30 | Corning Incorporated | Devices and methods for generation and culture of 3d cell aggregates |
WO2022120391A1 (fr) * | 2020-12-04 | 2022-06-09 | The Trustees Of The University Of Pennsylvania | Ingénierie génétique de culture d'organoïdes pour une organogenèse améliorée dans un plat |
US20220243172A1 (en) * | 2020-06-25 | 2022-08-04 | Next & Bio Inc. | Standard organoid production method |
WO2022175898A1 (fr) * | 2021-02-19 | 2022-08-25 | Molecular Devices (Austria) GmbH | Procédés pour le passage d'organoïdes utilisant des unités de microplaques à puits |
-
2023
- 2023-11-03 WO PCT/US2023/036772 patent/WO2024112417A1/fr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170342363A1 (en) * | 2014-10-29 | 2017-11-30 | Corning Incorporated | Devices and methods for generation and culture of 3d cell aggregates |
US20220243172A1 (en) * | 2020-06-25 | 2022-08-04 | Next & Bio Inc. | Standard organoid production method |
WO2022120391A1 (fr) * | 2020-12-04 | 2022-06-09 | The Trustees Of The University Of Pennsylvania | Ingénierie génétique de culture d'organoïdes pour une organogenèse améliorée dans un plat |
WO2022175898A1 (fr) * | 2021-02-19 | 2022-08-25 | Molecular Devices (Austria) GmbH | Procédés pour le passage d'organoïdes utilisant des unités de microplaques à puits |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6703476B2 (ja) | スフェロイド細胞培養ウェル製品およびその方法 | |
US11767499B2 (en) | Cell culture vessel | |
JP7250755B2 (ja) | 細胞培養容器 | |
US20200181552A1 (en) | Handling features for microcavity cell culture vessel | |
US8470258B2 (en) | Surface-structured device for life-science applications | |
JP5676265B2 (ja) | 細胞保存方法、及び細胞輸送方法 | |
WO2009148507A1 (fr) | Appareil de culture cellulaire à topographie variable | |
KR20170003177A (ko) | 다각형 마이크로 플레이트, 이의 제조방법 및 이를 이용한 세포 집합체의 배양방법 | |
JP2020527345A6 (ja) | 細胞培養容器 | |
CN103255057B (zh) | 一种细胞培养微流控芯片及其制备方法和应用 | |
US20240034969A1 (en) | Microplate wells for cell cultivation | |
WO2010025515A1 (fr) | Procédé pour fabriquer des dispositifs de culture de cellules microstructurés | |
WO2024112417A1 (fr) | Microplaques à structure de rétention et leur procédé d'utilisation | |
JP7318156B2 (ja) | 生体材料の培養用ウェル | |
US20230193182A1 (en) | Multiplanar microfluidic devices with multidirectional direct fluid communication among adjacent microfluidic channels | |
US20230383226A1 (en) | Microcavity plate | |
US20230357688A1 (en) | Culture vessels containing 3d cell culture substrates with diffusion structures | |
US20230256449A1 (en) | Micro-droplet dish | |
US6410310B1 (en) | Cell culture expansion plate | |
RU184220U1 (ru) | Клеточная ячейка микрофлюидного чипа для культивирования и/или исследования клеток или клеточных моделей | |
US11857970B2 (en) | Cell culture vessel | |
WO2024050645A1 (fr) | Dispositifs de laboratoire et procédés associés | |
KR102293014B1 (ko) | 세포 배양용 플랫폼 제공을 위한 마이크로 웰 어레이 제조방법 및 이에 의해 제조된 세포 배양용 플랫폼 제공을 위한 마이크로 웰 어레이 | |
KR20200008688A (ko) | 3차원 세포 배양 에세이 | |
CN111548939B (en) | Organoid perfusion culture chip and application method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23821759 Country of ref document: EP Kind code of ref document: A1 |